ABVC BioPharma, Inc. (ABVC)
0.83
+0.03
(+4.31%)
USD |
NASDAQ |
Aug 28, 16:00
0.8171
-0.01
(-1.55%)
After-Hours: 20:00
ABVC BioPharma Cash from Investing (Quarterly) : -0.1015M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1015M |
| March 31, 2026 | 0.0471M |
| December 31, 2025 | -0.0297M |
| September 30, 2025 | -0.5134M |
| June 30, 2025 | -0.6658M |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.0448M |
| June 30, 2024 | -0.5016M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.1542M |
| September 30, 2023 | -0.0738M |
| June 30, 2023 | -0.4406M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.0833M |
| September 30, 2022 | -1.523M |
| June 30, 2022 | -0.022M |
| March 31, 2022 | -0.0932M |
| December 31, 2021 | |
| September 30, 2021 | -0.3424M |
| June 30, 2021 | -0.14M |
| March 31, 2021 | -0.282M |
| December 31, 2020 | 1.084M |
| September 30, 2020 | -0.3658M |
| June 30, 2020 | 0.0333M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.0002M |
| September 30, 2019 | -0.0141M |
| June 30, 2019 | -0.0032M |
| March 31, 2019 | -0.0178M |
| December 31, 2018 | -0.4707M |
| September 30, 2018 | 0.2055M |
| June 30, 2018 | 0.1088M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0646M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -1.28M |
| Perspective Therapeutics, Inc. | 15.02M |
| MiMedx Group, Inc. | -0.635M |
| Abbott Laboratories | -673.00M |
| AngioDynamics, Inc. | -1.27M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.2444M |
| Cash from Financing (Quarterly) | 0.2262M |
| Free Cash Flow | -2.697M |
| Free Cash Flow Per Share (Quarterly) | -0.0094 |
| Free Cash Flow to Equity (Quarterly) | -0.4006M |
| Free Cash Flow to Firm (Quarterly) | -0.2021M |
| Free Cash Flow Yield | -13.02% |